NDA 218012 describes SUNITINIB MALATE, which is a drug marketed by
Dr Reddys,
Mylan,
Natco Pharma,
Novugen,
Sun Pharm, and
Teva Pharms Usa, and is included in six NDAs. It is available from
six suppliers. Additional details are available on the
SUNITINIB MALATE profile page.
The generic ingredient in SUNITINIB MALATE is
sunitinib malate. There are eight
drug master file entries for this compound. Eight
suppliers are listed for this compound. Additional details are available on the
sunitinib malate profile page.